reviews of glp 1 A new review by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, describes a new generation treatment with GLP-1 receptor agonists for persons with obesity with or without diabetes or GLP-1 Reviews 2026: Compare 70+

Compared with the healthy control group, the intestinal metabolite profile of patients with community-acquired pneumonia (CAP) showed significant changes

We limit our discussion in this review to peptides and small molecules that were specifically trialed in a general obesity population between 2004 and 2022

Unlike older weight loss medications, tirzepatide's dual-receptor approach produces sustained weight reduction in clinical trials, with patients losing 20-25% of body weight over 68 weeks

Tasha, Age 27 I was nervous about getting it done

Your PEAK clinician takes your individual response into account and can switch medications if one is not working well for you

no antibiotics are necessary unless the uveitis is persistent or recurrent